Tech Company Financing Transactions

Progenity Funding Round

Athyrium Opportunities Fund and private investors participated in a $125 million Series B capital raise for Progenity. The funding round was announced on 11/9/2017.

Transaction Overview

Company Name
Announced On
11/9/2017
Transaction Type
Venture Equity
Amount
$125,000,000
Round
Series B
Investors

Athyrium Opportunities Fund (Lead Investor) (Jeffrey Ferrell)

Proceeds Purpose
The net proceeds from this financing will be used to accelerate development of our transformative gastrointestinal (GI) platform targeting diagnostics and therapeutics for the GI tract, including precision molecular diagnostics tools, precision therapeutics, microbiome analytics, and consumer health nutrition. In addition, the proceeds will be used to enhance our menu and service offerings to our physician clients in the Prenatal and broader Women's Health market on a national scale.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
5230 S. State Rd.
Ann Arbor, MI 48108
USA
Email Address
Not Recorded
Overview
Progenity (Nasdaq: PROG) is a CLIA-accredited laboratory and is accredited by the College of American Pathologists (CAP). We operate across the United States.
Profile
Progenity LinkedIn Company Profile
Social Media
Progenity Company Twitter Account
Company News
Progenity News
Facebook
Progenity on Facebook
YouTube
Progenity on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Harry Stylli
  Harry Stylli LinkedIn Profile  Harry Stylli Twitter Account  Harry Stylli News  Harry Stylli on Facebook
Chief Financial Officer
Eric d'Esparbes
  Eric d'Esparbes LinkedIn Profile  Eric d'Esparbes Twitter Account  Eric d'Esparbes News  Eric d'Esparbes on Facebook
Chief Information Officer
Troy Seelye
  Troy Seelye LinkedIn Profile  Troy Seelye Twitter Account  Troy Seelye News  Troy Seelye on Facebook
Chief Operating Officer
Damon Silvestry
  Damon Silvestry LinkedIn Profile  Damon Silvestry Twitter Account  Damon Silvestry News  Damon Silvestry on Facebook
Chief Scientific Officer
Matthew Cooper
  Matthew Cooper LinkedIn Profile  Matthew Cooper Twitter Account  Matthew Cooper News  Matthew Cooper on Facebook
VP - Bus. Development
Sami Shihabi
  Sami Shihabi LinkedIn Profile  Sami Shihabi Twitter Account  Sami Shihabi News  Sami Shihabi on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/9/2017: AMTdirect venture capital transaction
Next: 11/9/2017: Qubole venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary